Phase IIb, randomised, multicentre, single blinded (outcomes blind to treatment arm) trial of intravenous tenecteplase (TNK) versus alteplase (tPA) in...
<1/3 middle cerebral artery territory. The primary hypothesis being tested in this trial is that ischaemic stroke patients treated with TNK will have greater reperfusion (measured at 24 hours) than tPA. Secondary outcomes include early clinical improvement and parenchymal haematoma.
Read more...